Clinical trial
Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery…
NCT00072033 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00072033 |
|---|---|
| Title | Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer |
| Official title | Docetaxel and Cisplatin Chemo- and Radiochemotherapy Followed by Surgery in Patients With Locally Advanced Esophageal Cancer - A Multicenter Phase II Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug |
| Interventions | Cisplatin and Docetaxel |
| Enrollment | 66 |
| Start date | Mar 1, 2003 |
| Primary completion | Mar 1, 2003 |
| Completion | May 1, 2010 |
| First posted | Nov 6, 2003 |
| Last update posted | Jun 5, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: